Related Experiment Videos
Pharmacoeconomics under defined contributions and tiered formularies
Clinical Therapeutics
|October 9, 2001
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Decision-makers' use of pharmacoeconomics: what does the research tell us?
Expert review of pharmacoeconomics & outcomes research·2009
Use and costs of ambulatory care services among Medicare enrollees with schizophrenia.
Psychiatric services (Washington, D.C.)·2001
Lower body osteoarticular pain and dose of analgesic medications in older disabled women: the Women's Health and Aging Study.
American journal of public health·1999
The effect of managed care on prescription drug costs and benefits.
PharmacoEconomics·1999
Services to families of adults with schizophrenia: from treatment recommendations to dissemination.
Psychiatric services (Washington, D.C.)·1999
Pharmaceutical Expenditure Governance in the UK and Italy.
European journal of health law·2026
Ketogenic diet therapy for epilepsy in Australia: insights from the Pharmaceutical Benefits Scheme.
Internal medicine journal·2026
Assessment of IPAY 2027 Medicare drug price negotiation maximum fair prices with prices in most-favored nation reference countries.
Journal of managed care & specialty pharmacy·2026
First Year Of ACO Realizing Equity, Access, And Community Health Program Yields Good Quality, Savings Results.
Health affairs (Project Hope)·2026
Spending Impact of the First 10 Drugs Selected for Medicare Drug Price Negotiation in the United States.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Estimating US savings on outpatient prescription pharmaceuticals from international reference pricing.
Proceedings of the National Academy of Sciences of the United States of America·2026